Clinical Trial of DA-5212 in Patients with Functional Dyspepsia

A Phase 3 Clinical Trial to Evaluate the Efficacy and Safety of DA-5212 in Patients with Functional Dyspepsia

This study is to evaluate efficacy and safety of DA-5212 in patients with functional dyspepsia

Inclusion Criteria:

• Men or women ≥ 19 years of age
• Patients who diagnosed with functional dyspepsia
• Patients with no organic cause for digestive symptoms found by upper gastrointestinal endoscopy at screening visit

Exclusion Criteria:

• Patients with organic disease or medical history that may cause dyspepsia within 6 months before screening visit
• Patients who have a history of drugs or alcohol abuse and dependence within 6 months before screening visit
• Patients with hypersensitivity to investigational drugs and similar drugs
• Pregnant or breastfeeding women